Document Detail


Pharmacological cardiac stress: when and how?
MedLine Citation:
PMID:  7970439     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pharmacological stress is vital to the modern nuclear cardiological laboratory. In clinical practice only adenosine, dipyridamole and dobutamine are used. Both adenosine (directly) and dipyridamole (indirectly) work via activation of alpha 2 receptors, which causes vasodilatation. Adenosine has a very short half-life and any adverse effects can be rapidly controlled. It is however more expensive and not yet commercially available in the UK when compared with dipyridamole, which has a prolonged 30-min half-life. Dobutamine is a beta-agonist which mimics exercise by raising the rate pressure product, and it also has a short half-life. Adenosine and dipyridamole share some contraindications which include asthma. Dobutamine has been shown to be safe in these patients. Exaggerated responses to adenosine are seen in sinoatrial disease and in patients taking maintenance dipyridamole treatment orally. The adenosine receptor antagonists must be avoided prior to the use of the vasodilators (caffeine 12 h, aminophylline/theophylline 24 h). There is no evidence to suggest any significant difference between pharmacological stress and maximal exercise for myocardial perfusion imaging, but pharmacological stress is necessary for patients who have no exercise capability. Studies which show that submaximal exercise reduces sensitivity suggest that pharmacological stress should also be used in patients whose exercise capacity is suboptimal. The addition of exercise to the vasodilator infusion has been shown to reduce non-cardiac side effects and improve imaging.
Authors:
D J Pennell
Related Documents :
916129 - The incidental detection of gallium-67 citrate in a urinoma following a right pyeloplas...
25237749 - Experimental studies of the molecular pathways regulated by exercise and resveratrol in...
8045119 - Computed tomographic evaluation of maximal diaphragmatic crural thickness.
7983629 - Quantitative aspects of thyroid scintigraphy with pertechnetate (99mtco4-) in cats.
11382729 - Alleviation of myocardial ischemia after kawasaki disease by heparin and exercise therapy.
3169939 - Dipyridamole echocardiography in essential hypertensive patients with chest pain.
8829619 - Exercise training alters kinetics of antioxidant enzymes in rat tissues.
6844759 - Slow to fast shift in inspiratory muscle fibers during heat tachypnea.
24444199 - Physical match performance of youth football players in relation to physical capacity.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Nuclear medicine communications     Volume:  15     ISSN:  0143-3636     ISO Abbreviation:  Nucl Med Commun     Publication Date:  1994 Aug 
Date Detail:
Created Date:  1994-12-28     Completed Date:  1994-12-28     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  8201017     Medline TA:  Nucl Med Commun     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  578-85     Citation Subset:  IM    
Affiliation:
Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine / diagnostic use*
Adrenergic beta-Agonists / diagnostic use*
Dipyridamole / diagnostic use*
Exercise Test*
Heart / physiopathology*,  radionuclide imaging*
Humans
Stress, Physiological / physiopathology*
Vasodilator Agents / contraindications,  diagnostic use*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Vasodilator Agents; 58-32-2/Dipyridamole; 58-61-7/Adenosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Radiochemical purity testing for 99Tcm-exametazime: a comparison study for three-paper chromatograph...
Next Document:  201Tl myocardial perfusion SPET: adenosine alone or combined with dynamic exercise.